High 8.1Published Oct 29, 2026

CVE-2026-119050Agno through 3.1.11 Code Execution via PandasTools Unsafe Reflection

Updated under an hour ago (Oct 30, 2026, 2:30 AM ET)

Does this affect you?

It affects agno-agi agno. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Do this next

Start free and add your stackFree account, 3 products Every CVE for agno-agi agno Exploited in the last 30 days

Agno through 3.1.11 contains an unsafe reflection vulnerability in PandasTools that allows attackers to invoke arbitrary pandas functions by supplying model-controlled function names to getattr(). Attackers can use prompt injection to make the agent call pandas.read_pickle on attacker-controlled paths for code execution, or call other readers to read local files.

CVSS: 8.1 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE): CWE-470
Known exploited: Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days): Not loaded for this CVE
Assigned by: VulnCheck
NVD analysis: Deferred
Record last updated: Oct 29, 2026
First seen by InfoSec Signals: Oct 29, 2026

Affected products

Affected products

agno-agi agno agno_agi:agno (from the name)	through 3.1.11	CNA record

References

References

https://github.com/agno-agi/agno/issues/8699	issue-tracking
https://github.com/agno-agi/agno	product
https://github.com/agno-agi/agno/blob/d9ab0a758286142e7d998ef313ee7504d7fd9453/libs/agno/agno/tools/pandas.py#L54	technical-description
https://github.com/agno-agi/agno/blob/d9ab0a758286142e7d998ef313ee7504d7fd9453/libs/agno/agno/tools/pandas.py#L90	technical-description
https://www.vulncheck.com/advisories/agno-through-3.1.11-code-execution-via-pandastools-unsafe-reflection	third-party-advisory

The CVE record on cve.org NVD's entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.